Menu
Back to Journals » Journal of Asthma and Allergy » Volume 14
Corrigendum
Profile of Anti-IL-5 mAb Mepolizumab in the Treatment of Severe Refractory Asthma and Hypereosinophilic Diseases [Corrigendum]
| Total article views | HTML views | PDF downloads | Totals | ||
|---|---|---|---|---|---|
| 2,532 | Dovepress* | 2,445+ | 323 | 2,768 | |
| PubMed Central* | 87 | 41 | 128 | ||
| Totals | 2,532 | 364 | 2,896 | ||
| *Since 29 June 2021 | |||||
View citations on PubMed Central and Google Scholar